Tag Archives: CRIS

Top 5 Safest Stocks To Invest In Right Now

&l;img class=&q;dam-image getty size-large wp-image-1125913011&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1125913011/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g;

It&s;s awfully tempting. You see that money in your 401(k) plan account just sitting there. And you think of all the possible uses for it. Why not take a loan? You will pay it back — with interest!

Generally, that is a really bad idea. Here are the reasons why.

&l;strong&g;You will likely forfeit some company matching contributions&l;/strong&g;

Many individuals who borrow from their 401(k) accounts end up stopping or lowering their contributions while they are paying back their loans. This often results in the loss of 401(k) matching contributions when their contribution rates fall below the maximum matched percentage.

There is no better investment you can make than receiving free money in the form of company matching contributions. It is the safest, easiest way to earn 25%, 50% or 100% — depending upon your company&s;s matching percentage.

Top 5 Safest Stocks To Invest In Right Now: Akamai Technologies, Inc.(AKAM)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Click here to learn more.

    Stocks to Watch Today: GILD, AMZN, UAA, JPM, AAPL, NFLX
    Shares of Gilead Sciences Inc. (NASDAQ: GILD) fell 2.4% after the biotech giant announced disappointing results from a trial for a drug for chronic liver disease. In deal news, Amazon.com Inc. (NASDAQ: AMZN) will buy Wi-Fi/home router startup Eero for an undisclosed amount. The global e-commerce giant has been going on a smart-home acquisition streak. Last year, the firm bought video doorbell maker Ring for $1 billion. Eero is based in San Francisco and was founded in 2014. The firm makes mesh routers that aim to eliminate dead zones across a house or business location. Shares of Under Armour Inc. (NYSE: UAA) gained more than 2.2% after the company reported earnings before the bell. The sports apparel giant reported earnings per share of $0.09 (on an adjusted basis). That figure beat expectations of $0.04. The company’s sales were off about 6% in the fourth quarter but cited a big jump in foreign revenue. Last week, JPMorgan Chase & Co. (NYSE: JPM) released a report that recommended one of the deals of the decade. The bank has called for Apple Inc. (NASDAQ: AAPL) to buy streaming giant Netflix Inc. (NASDAQ: NFLX). This deal is a no-brainer in today’s market. We break down what a deal would look like, how it benefits both sides, and how it would be like rocket fuel for Apple stock. Here’s what you need to know. Look for earnings reports from Activision Blizzard Inc. (NASDAQ: ATVI), Aircastle Ltd. (NYSE: AYR), Akamai Technologies Inc. (NASDAQ: AKAM), Ares Capital Corp. (NASDAQ: ARCC), Denny’s Corp. (NASDAQ: DENN), Groupon Inc. (NASDAQ: GRPN), HubSpot Inc. (NASDAQ: HUBS), Molson Coors Brewing Co. (NYSE: TAP), Occidental Petroleum Corp. (NYSE: OXY), Shopify Inc. (NASDAQ: SHOP), and TripAdvisor Inc. (NASDAQ: TRIP).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By ]

    There could be a for sale sign planted in the ground at tech pioneer Akamai (AKAM) .

    “We’re a public company and our board, which is very professional and diligent, is always going to do the right thing for shareholders,” Akamai CEO Tom Leighton told TheStreet when asked if the company he co-founded in 1998 was for sale. While Leighton left the door open on a possible sale, he added that Akamai has strong prospects as a stand-alone company as well.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Akamai Technologies (AKAM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Meanwhile, Akamai’s (AKAM) CEO Tom Leighton didn’t shut the door to a potential sale of the company in an interview with me. Recent speculation on Wall Street is that Akamai would be an ideal fit for IBM (IBM) . 

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Akamai Technologies (AKAM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Safest Stocks To Invest In Right Now: Dynavax Technologies Corporation(DVAX)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of Dynavax Technologies (NASDAQ:DVAX), a vaccine and immuno-oncology specialist, dropped by 15.9% last month, according to data from S&P Global Market Intelligence. What sparked this sell-off?

  • [By Motley Fool Transcription]

    Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2018 Earnings Conference Call February 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Dynavax Technologies alerts:

    Dynavax Technologies Co. (DVAX) Receives Average Recommendation of “Buy” from Brokerages (americanbankingnews.com) Earnings per share (EPS) in the Spotlight – Dynavax Technologies Corporation (NASDAQ: DVAX) (stocksmarketcap.com) Is the Stock Safe to Invest? – Dynavax Technologies Corporation (NASDAQ:DVAX) (nasdaqjournal.com) Investor’s Watch List: Dynavax Technologies Corporation (DVAX) (nasdaqplace.com) You Need to Watch this stock? Dynavax Technologies Corporation (DVAX) (connectinginvestor.com)

    DVAX has been the topic of several analyst reports. Cantor Fitzgerald set a $27.00 price objective on Dynavax Technologies and gave the company a “buy” rating in a research note on Wednesday, May 16th. ValuEngine lowered Dynavax Technologies from a “hold” rating to a “sell” rating in a research note on Tuesday, May 1st. BidaskClub downgraded Dynavax Technologies from a “buy” rating to a “hold” rating in a report on Sunday, April 22nd. Finally, JPMorgan Chase & Co. raised Dynavax Technologies from a “neutral” rating to an “overweight” rating and set a $25.00 target price on the stock in a report on Thursday, May 10th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the stock. Dynavax Technologies currently has a consensus rating of “Buy” and an average target price of $24.67.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Dynavax Technologies (DVAX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    For Dynavax Technologies Corporation (NASDAQ:DVAX), this old adage was spot-on. Between Jan. 1 and Nov. 8, 2017, the biotech stock increased more than fivefold. Investors eagerly awaited FDA approval of Dynavax’s Heplisav-B hepatitis B vaccine. After two unsuccessful attempts at approval, Heplisav-B finally won a green light from the FDA on Nov. 9. Since then, Dynavax’s share price has dropped 37%. 

Top 5 Safest Stocks To Invest In Right Now: Thor Industries Inc.(THO)

Advisors’ Opinion:

  • [By Keith Noonan, Rich Smith, and Tyler Crowe]

    For this roundtable, we asked three Motley Fool contributors to profile a company that has the makings of a long-term winner. Read on to see why they think that Thor Industries (NYSE:THO), Waste Management (NYSE:WM), and Activision Blizzard (NASDAQ:ATVI) are stocks that are poised to do big things over the next 20 years.

  • [By Asit Sharma]

    Leading recreational vehicle (RV) manufacturer Thor Industries, Inc. (NYSE:THO) reported a drop in revenue, as well as deterioration in several key financial metrics, in its fiscal fourth-quarter 2018 earnings report issued Thursday before the markets opened. The unexpectedly tepid performance jarred Thor shares, which traded down nearly 15% early in the trading session following the earnings release. Let’s review headline numbers below and uncover why shareholders found the report distasteful:

  • [By Ethan Ryder]

    Tahoe Resources (TSE:THO) (NASDAQ:TAHO) was downgraded by analysts at Beacon Securities from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. They currently have a C$5.75 price target on the stock, down from their prior price target of C$10.00. Beacon Securities’ price objective would indicate a potential upside of 61.52% from the company’s current price.

  • [By Logan Wallace]

    Tahoe Resources (TSE:THO) (NASDAQ:TAHO) – Equities research analysts at National Bank Financial reduced their FY2018 earnings estimates for shares of Tahoe Resources in a research report issued on Monday, April 9th. National Bank Financial analyst M. Parkin now forecasts that the company will earn $0.29 per share for the year, down from their prior forecast of $0.35. National Bank Financial currently has a “Sector Perform” rating and a $8.00 price objective on the stock.

  • [By Ethan Ryder]

    First Allied Advisory Services Inc. lowered its position in Thor Industries, Inc. (NYSE:THO) by 20.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 4,104 shares of the construction company’s stock after selling 1,060 shares during the period. First Allied Advisory Services Inc.’s holdings in Thor Industries were worth $401,000 at the end of the most recent quarter.

Top 5 Safest Stocks To Invest In Right Now: American River Bankshares(AMRB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on American River Bankshares (AMRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on American River Bankshares (AMRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    American River Bankshares (NASDAQ:AMRB) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.

Top 5 Safest Stocks To Invest In Right Now: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in patients with NASH at 36 weeks in Phase 2 trial.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose 31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Curis, Inc. (NASDAQ: CRIS) shares rose 27.2 percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in patients with relapse, refractory diffuse large B-cell lymphoma.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent to $2.51 in pre-market trading.
    Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to $14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook.
    Express, Inc. (NYSE: EXPR) rose 14.3 percent to $10.49 in pre-market trading after the company reported better-than-expected results for its first quarter.
    NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent to $12.10 in pre-market trading after reporting Q4 earnings beat.
    J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to $6.90 in pre-market trading after the company posted upbeat quarterly earnings.
    TapImmune, Inc. (NASDAQ: TPIV) shares rose 10 percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday.
    Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74 in pre-market trading after Q1 results beat estimates.
    Tech Data Corporation (NASDAQ: TECD) rose 8.8 percent to $89.65 in pre-market trading following better-than-expected Q1 earnings.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1 percent to $3.65 in pre-market tra
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY
  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Brian Feroldi]

    Curis, Inc. (NASDAQ:CRIS), a beaten up clinical-stage biopharma focused on cancer, jumped 23% as of 2:43 p.m. EDT on Thursday in response to announcing that one of its key compounds has received Food and Drug Administration (FDA) Fast Track designation.

  • [By Joseph Griffin]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

    Get Curis alerts:

    $2.41 Million in Sales Expected for Curis, Inc. (CRIS) This Quarter (americanbankingnews.com) Curis Stock Scheduled to Reverse Split on Wednesday, May 30th (CRIS) (americanbankingnews.com) Zacks: Analysts Expect Curis, Inc. (CRIS) to Post -$0.09 Earnings Per Share (americanbankingnews.com) Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development (finance.yahoo.com) Is Curis, Inc. (CRIS) In Search of Footing? (nmsunews.com)

    Shares of Curis stock traded up $0.01 on Monday, hitting $0.45. The company had a trading volume of 1,290,968 shares, compared to its average volume of 1,462,753. The stock has a market capitalization of $74.57 million, a PE ratio of -1.25 and a beta of 1.29. Curis has a twelve month low of $0.41 and a twelve month high of $2.27. The company has a quick ratio of 3.60, a current ratio of 3.60 and a debt-to-equity ratio of 2.24.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 18.2 percent to $4.55 in pre-market trading after the company declared a $0.70 per share special dividend.
    Co-Diagnostics, Inc. (NASDAQ: CODX) rose 11.7 percent to $3.24 in pre-market trading after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Abercrombie & Fitch Co. (NYSE: ANF) shares rose 8.6 percent to $25.95 in pre-market trading after the company posted upbeat Q1 results.
    Zuora, Inc. (NYSE: ZUO) shares rose 8 percent to $23.95 in pre-market trading after the company reported upbeat Q1 earnings and issued strong outlook.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares rose 7.8 percent to $113.25 in pre-market trading after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    OPKO Health, Inc. (NYSE: OPK) rose 5.7 percent to $4.10 in pre-market trading.
    Lannett Company, Inc. (NYSE: LCI) rose 5.5 percent to $17.45 in pre-market trading following the FDA approval for Levofloxacin Oral Solution.
    Eversource Energy (NYSE: ES) shares rose 5 percent to $59.8 in pre-market trading.
    VMware, Inc. (NYSE: VMW) rose 4.6 percent to $143.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Thursday.
    Energy Transfer Partners, L.P. (NYSE: ETP) rose 4.3 percent to $19.80 in pre-market trading after the company reported the Federal Energy Regulatory Commission approval to place Rover pipeline’s full Mainline B into service.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 4.3 percent to $7.73 in pre-market trading after declining 4.26 percent on Thursday.
    Curis, Inc. (NASDAQ: CRIS) rose 4.3 percent to $2.90 in pre-market trading after jumping 21.93 percent on Thursday.
    Sasol Limited (NYSE: SSL) rose 4.2 percent to $37.91 in pre-market trading.
    Nucor Corporatio

Hot Performing Stocks To Watch For 2019

Verizon Communications Inc. (NYSE: VZ) replaces Exxon Mobil this week as the worst-performing stock on the Dow Jones Industrial Average (DJIA) index, a position it last held in February. The stock has lost 8.84% for the year to date.

The shares dropped by just 9 cents last week (less than 0.2%), but that was enough to drop the stock to the bottom of the Dow 30.

Investors remain concerned about the hit to revenues that may follow the adoption of the company’s unlimited data plan. With all four major U.S. wireless carriers now offering unlimited data plans, has the industry embarked on a race to the bottom?

Analysts at Jefferies warned:

While the industry remains bullish on growth in data usage, and metered plans allow for some continued enthusiasm, the move by every carrier to unlimited plans will cause carriers to hope for less and less data usage. Almost every pricing action over the last couple of years has continued to take the roof down on ARPU growth opportunities as more and more data was offered for the same, or lower price point. Now with the advent of unlimited plans, the upside from additional usage is gone for those choosing aggressively priced unlimited plans.

Hot Performing Stocks To Watch For 2019: Dillard's, Inc.(DDS)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Yet that big post-earnings plunge didn’t make Macy’s the worst-performing department store stock of the past week. Shares of J.C. Penney and Sears Holdings have plunged about 30% during the same period, after those companies reported bad news last week. Even regional department store chain Dillard’s (NYSE:DDS) — which, like Macy’s, posted better-than-expected Q2 results — has experienced a steep sell-off in the past few days.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Walmart Inc. (NYSE: WMT) to report quarterly earnings at $1.13 per share on revenue of $120.51 billion before the opening bell. Walmart shares gained 1 percent to $86.99 in after-hours trading.
    Analysts expect Applied Materials, Inc. (NASDAQ: AMAT) to post quarterly earnings at $1.14 per share on revenue of $4.45 billion after the closing bell. Applied Materials shares rose 0.15 percent to $55.25 in after-hours trading.
    Jack in the Box Inc. (NASDAQ: JACK) reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent. Jack in the Box shares dropped 3.03 percent to $88.60 in the after-hours trading session.
    Before the opening bell, Dillard's, Inc. (NYSE: DDS) is estimated to report quarterly earnings at $2.77 per share on revenue of $1.46 billion. Dillard's shares rose 0.14 percent to $72.10 in after-hours trading.
    Analysts are expecting Childrens Place Inc (NASDAQ: PLCE) to have earned $2.21 per share on revenue of $444.14 million in the latest quarter. Childrens Place will release earnings before the markets open. Childrens Place shares gained 0.29 percent to $138.40 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Dan Caplinger]

    Thursday was a great day on Wall Street, as major benchmarks responded favorably to news that the U.S. and China would meet again to try to negotiate their differences on the trade front. The manufacturing-heavy Dow Jones Industrial Average fared the best out of the most-followed indexes, reflecting the key role that global trade plays in those companies’ opportunities for revenue growth and profit. Broader-based measures did well but weren’t able to keep up with the Dow in percentage terms. Still, some individual companies suffered from bad news that sent their shares lower. Dillard’s (NYSE:DDS), MiMedx Group (NASDAQ:MDXG), and Global Net Lease (NYSE:GNL) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Joseph Griffin]

    Shares of Dillard’s (NYSE:DDS) have been given an average recommendation of “Hold” by the eight brokerages that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $78.25.

Hot Performing Stocks To Watch For 2019: Gladstone Investment Corporation(GAIN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    UGAIN (CURRENCY:GAIN) traded down 5.6% against the US dollar during the 1 day period ending at 15:00 PM Eastern on May 20th. Over the last week, UGAIN has traded down 9.7% against the US dollar. One UGAIN coin can now be bought for about $0.0020 or 0.00000024 BTC on exchanges including CoinExchange and YoBit. UGAIN has a market cap of $0.00 and $1,395.00 worth of UGAIN was traded on exchanges in the last day.

  • [By Taylor Cox]

    Investor Events

    Gladstone Capital Corporation (NASDAQ: GLAD) and Gladstone Investment Corporation (NASDAQ: GAIN) each holding an analyst/investor day
    Micron Technology, Inc (NASDAQ: MU) holding analyst/investor day
    Baxter International Inc (NYSE: BAX) investor conference

    Tuesday
    Notable Earnings

  • [By Joseph Griffin]

    UGAIN (CURRENCY:GAIN) traded flat against the dollar during the 1-day period ending at 22:00 PM Eastern on September 16th. UGAIN has a market cap of $0.00 and $0.00 worth of UGAIN was traded on exchanges in the last 24 hours. One UGAIN coin can currently be bought for approximately $0.0013 or 0.00000016 BTC on popular exchanges. Over the last seven days, UGAIN has traded flat against the dollar.

  • [By Joseph Griffin]

    UGAIN (CURRENCY:GAIN) traded flat against the US dollar during the 24 hour period ending at 14:00 PM Eastern on September 10th. UGAIN has a total market cap of $0.00 and $0.00 worth of UGAIN was traded on exchanges in the last day. During the last week, UGAIN has traded flat against the US dollar. One UGAIN coin can now be purchased for $0.0013 or 0.00000016 BTC on exchanges.

  • [By Motley Fool Transcribers]

    Gladstone Investment Corp  (NASDAQ:GAIN)Q3 2019 Earnings Conference CallFeb. 06, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Gladstone Investment (GAIN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Performing Stocks To Watch For 2019: The First Bancshares, Inc.(FBMS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News articles about First Bancshares (NASDAQ:FBMS) have trended somewhat positive on Saturday, according to Accern Sentiment. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. First Bancshares earned a daily sentiment score of 0.23 on Accern’s scale. Accern also gave news coverage about the bank an impact score of 47.7532318171144 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Hot Performing Stocks To Watch For 2019: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Curis (CRIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in patients with NASH at 36 weeks in Phase 2 trial.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose 31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Curis, Inc. (NASDAQ: CRIS) shares rose 27.2 percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in patients with relapse, refractory diffuse large B-cell lymphoma.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent to $2.51 in pre-market trading.
    Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to $14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook.
    Express, Inc. (NYSE: EXPR) rose 14.3 percent to $10.49 in pre-market trading after the company reported better-than-expected results for its first quarter.
    NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent to $12.10 in pre-market trading after reporting Q4 earnings beat.
    J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to $6.90 in pre-market trading after the company posted upbeat quarterly earnings.
    TapImmune, Inc. (NASDAQ: TPIV) shares rose 10 percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday.
    Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74 in pre-market trading after Q1 results beat estimates.
    Tech Data Corporation (NASDAQ: TECD) rose 8.8 percent to $89.65 in pre-market trading following better-than-expected Q1 earnings.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1 percent to $3.65 in pre-market tra
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Curis (CRIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Curis (CRIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Performing Stocks To Watch For 2019: Rexnord Corporation(RXN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Rexnord (NYSE:RXN) announced its quarterly earnings results on Monday. The industrial products company reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.01), reports. Rexnord had a net margin of 8.29% and a return on equity of 13.05%.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Agilent Technologies, Inc. (NYSE: A) is estimated to post quarterly earnings at $0.64 per share on revenue of $1.21 billion.
    Vipshop Holdings Limited (NYSE: VIPS) is expected to post quarterly earnings at $0.18 per share on revenue of $3.10 billion.
    Rexnord Corporation (NYSE: RXN) is projected to post quarterly earnings at $0.39 per share on revenue of $551.94 million.
    Invitation Homes Inc. (NYSE: INVH) is estimated to post quarterly earnings at $0.03 per share on revenue of $423.13 million.
    Switch, Inc. (NYSE: SWCH) is expected to post quarterly earnings at $0.05 per share on revenue of $99.83 million.
    Itron, Inc. (NASDAQ: ITRI) is projected to post quarterly earnings at $0.13 per share on revenue of $579.85 million.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) is expected to post quarterly earnings at $0.44 per share on revenue of $119.06 million.
    Amyris, Inc. (NASDAQ: AMRS) is estimated to post quarterly earnings at $0.07 per share on revenue of $68.14 million.
    Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) is projected to post quarterly loss at $0.38 per share on revenue of $1.87 million.
    VOXX International Corporation (NASDAQ: VOXX) is expected to post quarterly earnings at $0.05 per share on revenue of $130.00 million.
    Phoenix New Media Limited (NYSE: FENG) is estimated to post quarterly loss at $0.12 per share on revenue of $45.38 million.
    Restoration Robotics, Inc. (NASDAQ: HAIR) is projected to post quarterly loss at $0.17 per share on revenue of $5.93 million.
    YogaWorks, Inc. (NASDAQ: YOGA) is estimated to post quarterly loss at $0.22 per share on revenue of

  • [By Stephan Byrd]

    ILLEGAL ACTIVITY NOTICE: “Todd A. Adams Sells 30,000 Shares of Rexnord Corp (RXN) Stock” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at www.tickerreport.com/banking-finance/4170556/todd-a-adams-sells-30000-shares-of-rexnord-corp-rxn-stock.html.

Top 5 Clean Energy Stocks To Watch For 2019

Brooks Automation (NASDAQ:BRKS) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report issued on Monday.

According to Zacks, “Brooks Automation is a leading worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy. Their technologies, engineering competencies, and global service capabilities provide customers speed to market, and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, they have been a leading partner to the global semiconductor manufacturing market and through product development initiatives and strategic business acquisitions; they have expanded their reach to meet the needs of customers in the life sciences industry, analytical & research markets, and clean energy solutions. “

Top 5 Clean Energy Stocks To Watch For 2019: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Curis (CRIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY
  • [By Brian Feroldi]

    Curis, Inc. (NASDAQ:CRIS), a beaten up clinical-stage biopharma focused on cancer, jumped 23% as of 2:43 p.m. EDT on Thursday in response to announcing that one of its key compounds has received Food and Drug Administration (FDA) Fast Track designation.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Curis (CRIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Clean Energy Stocks To Watch For 2019: Statoil ASA(STO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Statoil (NYSE: STO) and Delek US (NYSE:DK) are both oils/energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, dividends, profitability and risk.

  • [By Matthew DiLallo]

    Another highlight in April was that Shell gave the green light to the Vito project, which is a joint venture with Statoil (NYSE:STO) in the Gulf of Mexico. Shell and Statoil were able to cut that project’s cost estimate by 70% from the original design so that it’s now profitable at $35 a barrel. The partners expect the project to produce 100,000 BOE/D of low-cost oil and gas when it comes online in 2021.

  • [By Tyler Crowe]

    Anyone that has watched oil prices tick up recently has probably expected oil producers to report some impressive earnings results this past quarter, and Statoil (NYSE:STO) did just that with a 21% boost to the bottom line. At the same time, management is using all of its additional cash to do some wheeling and dealing that should help boost its growth possibilities in the nearer term.

Top 5 Clean Energy Stocks To Watch For 2019: Celgene Corporation(CELG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Celgene (NASDAQ:CELG) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.

  • [By Logan Wallace]

    Hemenway Trust Co LLC raised its stake in Celgene Co. (NASDAQ:CELG) by 45.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,706 shares of the biopharmaceutical company’s stock after acquiring an additional 21,836 shares during the period. Hemenway Trust Co LLC’s holdings in Celgene were worth $5,536,000 as of its most recent SEC filing.

  • [By George Budwell]

    Fortunately, there are a handful of names in biopharma that can double your net worth in a far less volatile manner. The only requirement is patience. The large-cap megapharmas AstraZeneca (NYSE:AZN) and Celgene Corporation (NASDAQ:CELG), for instance, are both slated to produce stellar returns on capital for investors in the next decade. With this in mind, here’s a look at each company’s key value drivers going forward. 

  • [By Keith Speights]

    Because of these risks, investing in gene-editing stocks like CRISPR Therapeutics (NASDAQ:CRSP) and Editas Medicine (NASDAQ:EDIT) isn’t for the faint of heart. There is a way, though, for investors to potentially profit from gene editing without taking on nearly as much risk. How? By buying the stocks of the small biotechs’ major partners. In particular, investors might want to consider Allergan (NYSE:AGN), Celgene (NASDAQ:CELG), and Vertex Pharmaceuticals (NASDAQ:VRTX).

  • [By ]

    Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .

  • [By Cory Renauer]

    This oncology-focused biotech out of Beijing went public in the U.S. in February 2016, but the stock has already risen around 520%. Investors are enthusiastic about a late-stage pipeline bursting with potential new cancer therapies of its own, plus the company has a license to sell Celgene’s (NASDAQ:CELG) therapies in a rapidly expanding domestic market.

Top 5 Clean Energy Stocks To Watch For 2019: Encore Wire Corporation(WIRE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    COPYRIGHT VIOLATION NOTICE: “Dean Investment Associates LLC Reduces Position in Encore Wire Co. (WIRE)” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at www.tickerreport.com/banking-finance/4153428/dean-investment-associates-llc-reduces-position-in-encore-wire-co-wire.html.

  • [By Max Byerly]

    BidaskClub cut shares of Encore Wire (NASDAQ:WIRE) from a hold rating to a sell rating in a research note issued to investors on Tuesday.

    A number of other research analysts also recently commented on the company. Zacks Investment Research raised Encore Wire from a sell rating to a hold rating in a report on Friday, August 10th. DA Davidson set a $60.00 target price on Encore Wire and gave the stock a buy rating in a report on Thursday, August 2nd. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. Encore Wire presently has a consensus rating of Hold and a consensus price target of $60.00.

  • [By Logan Wallace]

    Encore Wire (NASDAQ: WIRE) and Arconic (NYSE:ARNC) are both industrial products companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

Top 5 Clean Energy Stocks To Watch For 2019: NorthStar Realty Europe Corp.(NRE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Northstar Realty Europe Corp (NYSE:NRE) has earned an average rating of “Hold” from the six ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $16.83.

  • [By Shane Hupp]

    Teachers Insurance & Annuity Association of America increased its holdings in NorthStar Realty Europe (NYSE:NRE) by 15.7% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 71,499 shares of the financial services provider’s stock after purchasing an additional 9,699 shares during the period. Teachers Insurance & Annuity Association of America owned approximately 0.13% of NorthStar Realty Europe worth $931,000 as of its most recent SEC filing.

  • [By Jim Royal]

    Investors in NorthStar Realty Europe (NYSE:NRE) woke up to news Tuesday morning that one of the company’s largest investors is looking to shake things up at the company. Senvest Management, which owns 9.55% of NorthStar, is pushing the company’s external advisor, Colony Capital (NYSE:CLNY), to realize value at the undervalued European REIT, after years of a stagnating stock price.

  • [By Joseph Griffin]

    Pebblebrook Hotel Trust (NYSE: NRE) and Northstar Realty Europe (NYSE:NRE) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

  • [By Stephan Byrd]

    NorthStar Realty Europe (NYSE:NRE) has been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $17.17.

Top 10 Warren Buffett Stocks To Buy For 2019

Legendary investor Bill Miller is the former chairman and chief investment officer of Legg Mason Capital Management. He has been named fund manager of the decade by Morningstar and ranked as the top 30 most influential people in investing by SmartMoney. Below is an edited summary of his interview with The Investor’s Podcast where he talks about determining the intrinsic value of various companies like Amazon, Apple, and Tesla Motors.

Listen to this interview in your car by subscribing to the show on iTunes or Stitcher.

Preston Pysh: How does your approach differ from other famous value investors like Warren Buffett or Joel Greenblatt?

Bill Miller: Every value investor has a unique style, and my difference is that I am more eclectic. Buffett has said that he has moved on from the old Benjamin Graham style of deep values to a style that favors purchasing solid businesses at fair prices that compound on themselves. I am comfortable with both methods. Greenblatt used to prefer a concentrated style with high returns on capital, but now he has hundreds of companies with good financial characteristics in order to lower the volatility. On the contrary, I am skeptical of volatility. Since the financial crisis, volatility has been the price for performance in the risk-averse environment. I am willing to tolerate a lot more perceived risk in the portfolio than most other value investors.

Top 10 Warren Buffett Stocks To Buy For 2019: Churchill Downs, Incorporated(CHDN)

Advisors’ Opinion:

  • [By ]

    More than 157,000 people attended the 2018 Kentucky Derby at Churchill Downs (Nasdaq: CHDN) to watch Triple Crown winner Justify. The iconic 143-year-old facility generates $900 million in annual revenue, with gamblers placing $11 billion in horse wagers industrywide each year — not counting what they spend away from the pari-mutuel betting windows.

  • [By Stephan Byrd]

    Wells Fargo & Company MN decreased its holdings in Churchill Downs, Inc. (NASDAQ:CHDN) by 7.0% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 35,164 shares of the company’s stock after selling 2,629 shares during the period. Wells Fargo & Company MN owned approximately 0.26% of Churchill Downs worth $10,426,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Churchill Downs (CHDN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Churchill Downs Incorporated (NASDAQ:CHDN)’s share price reached a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $301.60 and last traded at $297.40, with a volume of 6596 shares trading hands. The stock had previously closed at $292.50.

  • [By ]

    Churchill Downs Inc (Nasdaq: CHDN) is known for its horse racing track in Kentucky but also owns nine casinos, four racetracks, a network of off-track betting sites and an online horse racing betting site. The individual casinos span eight states including population centers in New York, California, and Florida, and could all expand to sports betting as well.

  • [By ]

    Churchill Downs (CHDN) : “This has been a big winner for a long time. I’d wait for a dip, then buy some.”

    Devon Energy (DVN) : “They shot the lights out. They’ve got growth and are bigger than ever.”

Top 10 Warren Buffett Stocks To Buy For 2019: Johnson Controls Inc.(JCI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Webster Bank N. A. trimmed its stake in shares of Johnson Controls International PLC (NYSE:JCI) by 32.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,256 shares of the auto parts company’s stock after selling 2,576 shares during the period. Webster Bank N. A.’s holdings in Johnson Controls International were worth $184,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Logan Wallace]

    Amundi Pioneer Asset Management Inc. lifted its holdings in Johnson Controls International PLC (NYSE:JCI) by 8.7% in the 1st quarter, Holdings Channel reports. The firm owned 1,316,537 shares of the auto parts company’s stock after acquiring an additional 105,771 shares during the period. Amundi Pioneer Asset Management Inc.’s holdings in Johnson Controls International were worth $46,393,000 as of its most recent SEC filing.

  • [By Motley Fool Transcribers]

    Johnson Controls Inc  (NYSE:JCI)Q1 2019 Earnings Conference CallFeb. 01, 2019, 9:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By ]

    Johnson Controls (NYSE: JCI) yields 2.6% annually and has grown its dividend by 6.8% annually over the last five years. The 2016 merger with Tyco International has transitioned the business to less cyclical segments, including safety systems, and away from automotive manufacturing products.

  • [By Garrett Baldwin]

    Well, Money Morning Special Situation Strategist Tim Melvin has broken these secrets out of the vault of the Smart Money managers. And he’s sharing the Max Wealth secrets for free right here.

    Two Stocks to Watch Today: XOM, DB
    Shares of Exxon Mobil Corp. (NYSE: XOM) jumped more than 2.6% in pre-market hours after the energy giant reported earnings before the bell. The oil major reported earnings per share of $1.41, easily topping Wall Street forecasts of $1.08. Its $7.2 billion in quarterly profits were a 72% jump from the same period last year. However, the firm did fall a bit short on the revenue front. Investors liked the news that Exxon plans to restructure its upstream business to reduce costs and bolster operating cash flow by 2025. On the European front, shares of Deutsche Bank (NYSE: DB) were off another 3.72% after the German banking giant reported earnings. The embattled financial institution reported its first annual profit since 2014. However, broader uncertainty remains from investors. On Friday, look for earnings reports from Chevron Corp. (NYSE: CVX), Cigna Holding Co. (NYSE: CI), Weatherford International Plc. (NYSE: WFT), Roper Technologies Inc. (NYSE: ROP), Merck & Co. Inc. (NYSE: MRK), Honeywell International Inc. (NYSE: HON), and Johnson Controls International Plc. (NYSE: JCI).
    These 3 Stocks Are the Key to 2019’s Greatest Profits

    The 2018 midterm election was a turning point for the cannabis industry.

Top 10 Warren Buffett Stocks To Buy For 2019: ServiceMaster Global Holdings, Inc.(SERV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Servicemaster Global (NYSE:SERV) had its target price boosted by Stifel Nicolaus from $40.00 to $45.00 in a report published on Wednesday morning, The Fly reports. They currently have a buy rating on the business services provider’s stock. The analysts noted that the move was a valuation call.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Servicemaster Global (SERV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Servicemaster Global Holdings Inc (NYSE:SERV) hit a new 52-week high and low during trading on Thursday . The company traded as low as $59.70 and last traded at $59.03, with a volume of 15886 shares trading hands. The stock had previously closed at $59.62.

  • [By Max Byerly]

    ServiceMaster (NYSE:SERV)’s share price reached a new 52-week high and low during trading on Tuesday . The company traded as low as $55.63 and last traded at $54.76, with a volume of 207508 shares traded. The stock had previously closed at $55.35.

Top 10 Warren Buffett Stocks To Buy For 2019: Samsung Electronics Co. Ltd. (SSNLF)

Advisors’ Opinion:

  • [By Billy Duberstein]

    Micron also highlighted some impressive milestones in relation to its main competitors. Although it didn’t name them specifically, these are Samsung (NASDAQOTH:SSNLF) and SK Hynix (NASDAQOTH:HXSCL).

  • [By ]

    The Roku platform is the only purpose built OS for TVs and the company is benefiting from TV brands giving up on their own platforms (not all, like Samsung (OTC:SSNLF) still has Tizen).

  • [By Wayne Duggan]

    Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE: TSM) is the leading ASIC component supplier, but Samsung Electronics Co Ltd (OTC: SSNLF) is gaining ASIC market share, Li said. 

  • [By SEEKINGALPHA.COM]

    Samsung (OTC:SSNLF) will unveil its new flagship phones, the Galaxy S9 and Galaxy S9 Plus, on February 25 at Mobile World Congress event in Barcelona. Their new features could help the Galaxy S9 and Galaxy S9 Plus replicate the stellar success of the $999 iPhone X of Apple (AAPL). Canalys reported last month that Apple could have shipped out as much as 29 million units of its expensive iPhone X during Q4 2017.

  • [By ]

    ADT is taking aim at the resident-monitored market by partnering with technology provider Samsung (OTC:SSNLF) for a line of a do-it-yourself (DIY) home-security products. The products are supported by ADT’s monitoring service, and consumers can sign up for month-to-month plans. ADT will also integrate Ring Doorbells with its monitoring services if customers desire.

  • [By ]

    The largest and only manufacturer at scale, able to deliver to the high-demand growth markets for OLED screens (used for instance, in the latest Apple (NASDAQ:AAPL) iPhone products, Samsung (OTC:SSNLF) Galaxy S9, and multiple displays which bear the OLED technology), is Samsung…

Top 10 Warren Buffett Stocks To Buy For 2019: Union Pacific Corporation(UNP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Union Pacific (NYSE:UNP)‘s stock had its “hold” rating restated by equities research analysts at Cowen in a research note issued on Tuesday. They currently have a $151.00 target price on the railroad operator’s stock. Cowen’s target price points to a potential downside of 7.25% from the stock’s previous close.

  • [By Ethan Ryder]

    Deutsche Bank restated their hold rating on shares of Union Pacific (NYSE:UNP) in a report released on Friday morning.

    UNP has been the subject of a number of other reports. Morgan Stanley increased their price objective on shares of Union Pacific from $125.00 to $136.00 and gave the stock an equal weight rating in a research note on Friday, June 1st. Cowen restated a market perform rating and set a $153.00 price objective (up from $140.00) on shares of Union Pacific in a research note on Friday, June 1st. Zacks Investment Research downgraded shares of Union Pacific from a buy rating to a hold rating in a research note on Wednesday, August 8th. Robert W. Baird increased their price objective on shares of Union Pacific from $144.00 to $155.00 and gave the stock a neutral rating in a research note on Monday, June 4th. Finally, Loop Capital increased their price objective on shares of Union Pacific to $153.00 and gave the stock a hold rating in a research note on Friday, June 1st. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and ten have issued a buy rating to the company. Union Pacific presently has an average rating of Hold and an average price target of $147.35.

  • [By Lou Whiteman]

    Shares of Union Pacific Corp. (NYSE:UNP) gained 15.1% in January, according to data provided by S&P Global Market Intelligence, after a strong fourth-quarter performance gave investors confidence the railroad is on track to deliver in 2019.

  • [By Ethan Ryder]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get Union Pacific alerts:

    Union Pacific (UNP) Price Target Raised to $155.00 at Robert W. Baird (americanbankingnews.com) Seaport Global Securities Comments on Union Pacific Co.’s FY2019 Earnings (UNP) (americanbankingnews.com) Union Pacific Co. (UNP) Expected to Announce Quarterly Sales of $5.54 Billion (americanbankingnews.com) Zacks: Brokerages Anticipate Union Pacific Co. (UNP) Will Post Earnings of $1.88 Per Share (americanbankingnews.com) Jobs report shows we have 'perfect economy' for stocks (finance.yahoo.com)

    A number of equities research analysts recently issued reports on the company. Morgan Stanley lifted their target price on Union Pacific from $125.00 to $136.00 and gave the company an “equal weight” rating in a research report on Friday. Cowen reissued a “market perform” rating and issued a $153.00 target price (up previously from $140.00) on shares of Union Pacific in a research report on Friday. Robert W. Baird lifted their target price on Union Pacific from $144.00 to $155.00 and gave the company a “neutral” rating in a research report on Monday. TD Securities dropped their target price on Union Pacific from $155.00 to $150.00 and set a “buy” rating on the stock in a research report on Friday, April 27th. Finally, Loop Capital lifted their target price on Union Pacific to $153.00 and gave the company a “hold” rating in a research report on Friday. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and twelve have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $146.70.

  • [By Stephan Byrd]

    KCS Wealth Advisory grew its holdings in Union Pacific Co. (NYSE:UNP) by 12.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,729 shares of the railroad operator’s stock after purchasing an additional 422 shares during the quarter. KCS Wealth Advisory’s holdings in Union Pacific were worth $501,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Warren Buffett Stocks To Buy For 2019: Mercury Systems Inc(MRCY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Mercury Systems (NASDAQ: MRCY) and IntriCon (NASDAQ:IIN) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends and institutional ownership.

  • [By Stephan Byrd]

    Mercury Systems Inc (NASDAQ:MRCY) has been assigned a consensus recommendation of “Hold” from the nine research firms that are covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $52.00.

  • [By Shane Hupp]

    Wrapmanager Inc. bought a new stake in Mercury Systems Inc (NASDAQ:MRCY) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 9,543 shares of the technology company’s stock, valued at approximately $363,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Mercury Systems (MRCY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Mercury Systems Inc (NASDAQ:MRCY) reached a new 52-week high during trading on Monday . The stock traded as high as $55.58 and last traded at $55.42, with a volume of 5825 shares. The stock had previously closed at $54.31.

Top 10 Warren Buffett Stocks To Buy For 2019: Core Laboratories N.V.(CLB)

Advisors’ Opinion:

  • [By Todd Campbell]

    In the years since oil prices plunged from their $100-plus per barrel levels of 2014, many energy industry stocks have struggled — but now, they may be set to rebound. Economic growth worldwide and Middle Eastern production cuts have resulted in a more than doubling of crude oil prices since early 2016; if they remain near current levels or head higher, now could be the perfect time to add Hess Corp. (NYSE:HES), Diamond Offshore (NYSE:DO), and Core Labs (NYSE:CLB) to your portfolio.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Core Laboratories (CLB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    Oil stocks offer investors the chance to profit from global economic growth, and that might have you wondering what oil stocks are best for your portfolio today. There are many choices, but these three companies are well positioned to benefit from the current market environment. Read on to learn why oil stocks are worth owning and what makes ExxonMobil (NYSE:XOM), Hess Corp. (NYSE:HES), and Core Labs (NYSE:CLB) particularly compelling stocks to buy.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Core Laboratories (CLB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Core Laboratories’ (NYSE:CLB) financial results continued their steady improvement in the first quarter. While the company faced some headwinds from seasonality that caused results to flatten out versus the fourth quarter of 2017, they were still much better than the year-ago period. That progression should continue for the foreseeable future given the increasingly optimistic outlook for the oil market.

Top 10 Warren Buffett Stocks To Buy For 2019: Tree.com Inc.(TREE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Lendingtree (TREE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Rhumbline Advisers decreased its position in LendingTree (NASDAQ:TREE) by 13.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,988 shares of the financial services provider’s stock after selling 2,252 shares during the period. Rhumbline Advisers’ holdings in LendingTree were worth $4,590,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Demitrios Kalogeropoulos]

    Shares of consumer lending specialist LendingTree (NASDAQ:TREE) spiked 35% last month, trouncing the S&P 500’s 8% gain, according to data provided by S&P Global Market Intelligence.

  • [By Stephan Byrd]

    WINTON GROUP Ltd lessened its stake in Lendingtree Inc (NASDAQ:TREE) by 29.2% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,754 shares of the financial services provider’s stock after selling 1,134 shares during the period. WINTON GROUP Ltd’s holdings in Lendingtree were worth $589,000 at the end of the most recent quarter.

Top 10 Warren Buffett Stocks To Buy For 2019: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Curis (CRIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Curis (CRIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

    Get Curis alerts:

    $2.41 Million in Sales Expected for Curis, Inc. (CRIS) This Quarter (americanbankingnews.com) Curis Stock Scheduled to Reverse Split on Wednesday, May 30th (CRIS) (americanbankingnews.com) Zacks: Analysts Expect Curis, Inc. (CRIS) to Post -$0.09 Earnings Per Share (americanbankingnews.com) Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development (finance.yahoo.com) Is Curis, Inc. (CRIS) In Search of Footing? (nmsunews.com)

    Shares of Curis stock traded up $0.01 on Monday, hitting $0.45. The company had a trading volume of 1,290,968 shares, compared to its average volume of 1,462,753. The stock has a market capitalization of $74.57 million, a PE ratio of -1.25 and a beta of 1.29. Curis has a twelve month low of $0.41 and a twelve month high of $2.27. The company has a quick ratio of 3.60, a current ratio of 3.60 and a debt-to-equity ratio of 2.24.

  • [By Max Byerly]

    GSA Capital Partners LLP lessened its holdings in Curis, Inc. (NASDAQ:CRIS) by 82.1% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 342,022 shares of the biotechnology company’s stock after selling 1,571,186 shares during the period. GSA Capital Partners LLP owned about 1.03% of Curis worth $592,000 at the end of the most recent quarter.

  • [By Brian Feroldi]

    Curis, Inc. (NASDAQ:CRIS), a beaten up clinical-stage biopharma focused on cancer, jumped 23% as of 2:43 p.m. EDT on Thursday in response to announcing that one of its key compounds has received Food and Drug Administration (FDA) Fast Track designation.

Top 10 Warren Buffett Stocks To Buy For 2019: Credicorp Ltd.(BAP)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Credicorp Ltd. (NYSE:BAP) have been given a consensus recommendation of “Hold” by the nine ratings firms that are presently covering the company, Marketbeat reports. Six analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $253.00.

  • [By Max Byerly]

    CI Investments Inc. reduced its holdings in shares of Credicorp Ltd. (NYSE:BAP) by 85.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,420 shares of the bank’s stock after selling 136,150 shares during the quarter. CI Investments Inc.’s holdings in Credicorp were worth $5,317,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Schwab Charles Investment Management Inc. raised its holdings in Credicorp Ltd. (NYSE:BAP) by 0.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 94,025 shares of the bank’s stock after acquiring an additional 707 shares during the quarter. Schwab Charles Investment Management Inc. owned 0.12% of Credicorp worth $21,167,000 as of its most recent filing with the SEC.

  • [By Joseph Griffin]

    Credicorp (NYSE: BAP) and Bco Com Portugues (OTCMKTS:BPCGY) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Hot Safest Stocks To Buy For 2019

 Today, I will show you how to take our very best investment ideas and make them 10 times better…   That's right. Using this simple strategy, I believe every individual investor managing less than $10 million can earn 50% a year in safe stocks. Returns at this level can transform your retirement… or even build generational wealth.   But this doesn't mean you have to buy risky stocks. And I'm not talking about anything expensive, difficult, or complex. I'm just talking about taking our best, safest ideas… and making one tiny adjustment.   It's something anyone can do. And it's easy.    Can you really make 50% a year?   Yes. In fact, it's almost certain that you will. I'm not talking about generating a little extra income. I'm talking about a way to turn our best ideas into absolute home runs. I'm talking about the best way to make a fortune in the stock market.

Hot Safest Stocks To Buy For 2019: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Curis (CRIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Curis (CRIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY
  • [By Brian Feroldi]

    Curis, Inc. (NASDAQ:CRIS), a beaten up clinical-stage biopharma focused on cancer, jumped 23% as of 2:43 p.m. EDT on Thursday in response to announcing that one of its key compounds has received Food and Drug Administration (FDA) Fast Track designation.

Hot Safest Stocks To Buy For 2019: PACCAR Inc.(PCAR)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Paccar (PCAR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    New York State Teachers Retirement System decreased its position in shares of Paccar (NASDAQ:PCAR) by 0.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 535,919 shares of the company’s stock after selling 1,577 shares during the period. New York State Teachers Retirement System owned about 0.15% of Paccar worth $35,462,000 at the end of the most recent reporting period.

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Ethan Ryder]

    KBC Group NV increased its position in shares of Paccar (NASDAQ:PCAR) by 9.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 92,983 shares of the company’s stock after purchasing an additional 7,832 shares during the quarter. KBC Group NV’s holdings in Paccar were worth $6,153,000 at the end of the most recent reporting period.

  • [By ]

    “Companies ranging from Action Alerts PLUS holding Microsoft (MSFT)  to heavy-truck maker Paccar (PCAR)  have over the years declared so-called ‘special dividends’ — one-time extra payments to shareholders. With the new U.S. tax law granting corporations a limited window to repatriate overseas profits at low tax rates, many companies might use the extra cash for special dividends. Let’s discuss how this impacts income investors,” writes Real Money Pro columnist Christopher Versace.

  • [By Max Byerly]

    State of New Jersey Common Pension Fund D bought a new position in shares of Paccar (NASDAQ:PCAR) in the 1st quarter, Holdings Channel reports. The fund bought 160,000 shares of the company’s stock, valued at approximately $10,587,000.

Hot Safest Stocks To Buy For 2019: iShares MSCI Europe Financials Sector Index Fund(EUFN)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    The iShares MSCI Europe Financials ETF (NASDAQ: EUFN) is down just over 1 percent year-to-date. While it's not alarming decline by any mean, it's a broad view: a more focused look at EUFN reveals the exchange traded fund resides about 11 percent below the 52-week high it set in February.

Hot Safest Stocks To Buy For 2019: StoneMor Partners L.P.(STON)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.Stonemor Partners LP (STON) – 6,650,613 shares, 68.21% of the total portfolio. Shares added by 8.91%Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 21.11% of the total portfolio. Stage Stores Inc (SSI) – 1,750,000 shares, 6.3% of the total portfolio. Shares added by 75.00%Five Star Senior Living Inc (FVE) – 2,039,878 shares, 4.38% of the total portfolio. Added

Hot Safest Stocks To Buy For 2019: Cathay General Bancorp(CATY)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Cathay General Bancorp (CATY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Safest Stocks To Buy For 2019: Vascular Biogenics Ltd.(VBLT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion.
    J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion.
    Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion.
    The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million.
    Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million.
    Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million.
    KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million.
    Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share.
    Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million.
    Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.

     

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading.
    ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday.
    Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent.
    Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday.
    Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter.
    Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday.
    Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading.
    Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss.
    Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook.
    ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering